SAR441255
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR441255, covering 2025-09-22 to 2025-09-22. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects [Phase 1]